Education
About Us
Working with TipRanks
Follow Us
Zim Laboratories Ltd. (IN:ZIMLAB)
:ZIMLAB
ZIMLAB Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹79.50 - ₹128.45
Previous CloseN/A
Volume52.11K
Average Volume (3M)13.16K
Market Cap
₹5.26B
Enterprise Value₹5.06B
Total Cash (Recent Filing)₹27.99M
Total Debt (Recent Filing)₹1.18B
Price to Earnings (P/E)43.2
Beta0.79
Next Earnings
Aug 07, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 19, 2019Dividend YieldN/A
Share Statistics
EPS (TTM)1.00
Shares Outstanding48,725,815
10 Day Avg. Volume8,993
30 Day Avg. Volume13,165
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ZIMLAB FAQ
What was Zim Laboratories Ltd.’s price range in the past 12 months?
Zim Laboratories Ltd. lowest stock price was ₹79.50 and its highest was ₹128.45 in the past 12 months.
What is Zim Laboratories Ltd.’s market cap?
Zim Laboratories Ltd.’s market cap is ₹5.26B.
When is Zim Laboratories Ltd.’s upcoming earnings report date?
Zim Laboratories Ltd.’s upcoming earnings report date is Aug 07, 2025 which is in 3 days.
How were Zim Laboratories Ltd.’s earnings last quarter?
Zim Laboratories Ltd. released its earnings results on May 20, 2025. The company reported ₹1.002 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.002.
Is Zim Laboratories Ltd. overvalued?
According to Wall Street analysts Zim Laboratories Ltd.’s price is currently Overvalued.
Does Zim Laboratories Ltd. pay dividends?
Zim Laboratories Ltd. pays a Annually dividend of ₹0.167 which represents an annual dividend yield of N/A. See more information on Zim Laboratories Ltd. dividends here
What is Zim Laboratories Ltd.’s EPS estimate?
Zim Laboratories Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zim Laboratories Ltd. have?
Zim Laboratories Ltd. has 48,725,815 shares outstanding.
What happened to Zim Laboratories Ltd.’s price movement after its last earnings report?
Zim Laboratories Ltd. reported an EPS of ₹1.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.29%.
Which hedge fund is a major shareholder of Zim Laboratories Ltd.?
Currently, no hedge funds are holding shares in IN:ZIMLAB
Company Description
Zim Laboratories Ltd.
ZIM Laboratories Limited develops, manufactures, and supplies pharmaceutical formulation and pre formulation ingredients in India and internationally. The company provides technology-based drug delivery solutions and non-infringing proprietary manufacturing processes for generic pharmaceutical products in semi-finished and finished categories/formulations, such as granules, pellets, taste masked powders, suspensions, tablets, capsules, and oral thin films. It serves therapeutic areas, such as urology, gastroenterology, cardiology, and anticoagulants, as well as antibiotics and anti-infectives, NSAIDs/pain analgesics, and vitamins and supplements. ZIM Laboratories Limited was incorporated in 1984 and is based in Nagpur, India.
Technical Analysis
Albert David Ltd
―
Lyka Labs Limited
―
Medicamen Biotech Limited
―
Nectar Lifesciences Ltd.
―
Venus Remedies Limited
―